2S3-19159-04578
4 vaccinations
7 coded responses
36 check-ins
6 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 920 / CA
- Registered
- 2021-02-20
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-17
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Registered in v-safe
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
-
2021-03-10
Dose 2 — Pfizer-BioNTech
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
-
2021-03-17
Health check-in — day 7, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-24
- 2021-03-31
- 2021-04-07
-
2021-04-14
Survey response — day 35, dose 2MedDRA: Discharge, Headache, Lethargy, Productive cough, Self-medication, Wheezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Wheezing and productive coughing with dark discharge. Lethargic. Headache improves with ibuprofen.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Survey response — day 42, dose 2MedDRA: Cough, Mucosal discolouration, Productive cough — Feeling: Good · Be unable to do your normal daily activitiesFree text: Productive coughing with dark mucus, sometimes typical of heavy pollen season, getting better since Monday.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-11
-
2021-09-08
Survey response — 6 months, dose 2MedDRA: Lethargy, Productive cough, Respiratory tract infection, Sputum discoloured, Wheezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Had respiratory infection treated with doxycycline in mid-August. Had lethargy, wheezing, productive coughing with dark expectorant.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-08
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-13
-
2021-09-14
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2022-03-10
-
2022-05-10
Dose 4 — Moderna
- 2022-05-12
- 2022-05-13
-
2022-05-14
Survey response — days 1–6 daily, dose 4MedDRA: Paranasal sinus hypersecretion, Sleep disorder — Feeling: GoodFree text: Sinus post nasal drainage sleep disruptionMedDRA releases: 2024-11 · check-in free text available
- 2022-05-15
- 2022-05-16
- 2022-05-17
- 2022-05-24
-
2022-05-31
Survey response — day 21, dose 4MedDRA: Headache, Productive cough, Secretion discharge, Sputum discoloured — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Productive cough with brown mucus. Headache. Normal temperature.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-07
-
2022-06-14
Survey response — day 35, dose 4MedDRA: Productive cough, Wheezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Wheezing, productive coughMedDRA releases: 2024-11 · check-in free text available
- 2022-06-21
- 2022-08-09
- 2022-11-08
-
2023-05-10
Survey response — 12 months, dose 4MedDRA: Nasal septal operation, Respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-05-10
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-05-11
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Pfizer-BioNTech | |
| 2 | 2021-03-10 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
| 4 | 2022-05-10 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 7 — day 35, dose 2
Symptoms: Wheezing and productive coughing with dark discharge. Lethargic. Headache improves with ibuprofen.
Release 7 — day 42, dose 2
Symptoms: Productive coughing with dark mucus, sometimes typical of heavy pollen season, getting better since Monday.
Release 9 — 6 months, dose 2
Symptoms: Had respiratory infection treated with doxycycline in mid-August. Had lethargy, wheezing, productive coughing with dark expectorant.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Sinus post nasal drainage sleep disruption
Release 11 — day 21, dose 4
Symptoms: Productive cough with brown mucus. Headache. Normal temperature.
Release 12 — day 35, dose 4
Symptoms: Wheezing, productive cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Discharge | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lethargy | ✓ | ✓ | ✓ |
| SD | Mucosal discolouration | ✓ | ✓ | ✓ |
| SD | Nasal septal operation | · | · | ✓ |
| SD | Productive cough | ✓ | ✓ | ✓ |
| SD | Respiratory tract infection | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SD | Sputum discoloured | · | · | ✓ |
| SD | Wheezing | ✓ | ✓ | ✓ |
| SRO | Paranasal sinus hypersecretion | · | · | ✓ |
| SRO | Sleep disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release